Lotze MT - Search Results

1

IFN-gamma-inducing factor/IL-18 administration mediates IFN-gamma- and IL-12-independent antitumor effects.

Osaki T, Péron JM, Cai Q, Okamura H, Robbins PD, Kurimoto M, Lotze MT, Tahara H. Osaki T, et al. Among authors: lotze mt. J Immunol. 1998 Feb 15;160(4):1742-9. J Immunol. 1998. PMID: 9469432

2

Use of T-cell growth factors (interleukins 2, 4, 7, 10, and 12) in the evaluation of T-cell reactivity to melanoma.

Lotze MT, Zeh HJ 3rd, Elder EM, Cai Q, Pippin BA, Rosenstein MM, Whiteside TL, Herberman R. Lotze MT, et al. J Immunother (1991). 1992 Oct;12(3):212-7. doi: 10.1097/00002371-199210000-00015. J Immunother (1991). 1992. PMID: 1359903

3

Islet cell transplantation facilitated by gene transfer.

Tahara H, Mueller GM, Ricordi C, Robbins PD, Lotze MT. Tahara H, et al. Among authors: lotze mt. Transplant Proc. 1992 Dec;24(6):2975-6. Transplant Proc. 1992. PMID: 1466019 No abstract available.

4

Administration of recombinant IL-4 to humans regulates gene expression, phenotype, and function in circulating monocytes.

Wong HL, Lotze MT, Wahl LM, Wahl SM. Wong HL, et al. Among authors: lotze mt. J Immunol. 1992 Apr 1;148(7):2118-25. J Immunol. 1992. PMID: 1531998

5

IL-7 induces human lymphokine-activated killer cell activity and is regulated by IL-4.

Stötter H, Custer MC, Bolton ES, Guedez L, Lotze MT. Stötter H, et al. Among authors: lotze mt. J Immunol. 1991 Jan 1;146(1):150-5. J Immunol. 1991. PMID: 1670602

6

Mechanisms of immunologic antitumor therapy: lessons from the laboratory and clinical applications.

Lotze MT, Custer MC, Bolton ES, Wiebke EA, Kawakami Y, Rosenberg SA. Lotze MT, et al. Hum Immunol. 1990 Jun;28(2):198-207. doi: 10.1016/0198-8859(90)90020-p. Hum Immunol. 1990. PMID: 2190952 Review.

7

Cytokines alter target cell susceptibility to lysis. II. Evaluation of tumor infiltrating lymphocytes.

Stötter H, Wiebke EA, Tomita S, Belldegrun A, Topalian S, Rosenberg SA, Lotze MT. Stötter H, et al. Among authors: lotze mt. J Immunol. 1989 Mar 1;142(5):1767-73. J Immunol. 1989. PMID: 2493053

8

In vivo induction of IL-6 by administration of exogenous cytokines and detection of de novo serum levels of IL-6 in tumor-bearing mice.

McIntosh JK, Jablons DM, Mulé JJ, Nordan RP, Rudikoff S, Lotze MT, Rosenberg SA. McIntosh JK, et al. Among authors: lotze mt. J Immunol. 1989 Jul 1;143(1):162-7. J Immunol. 1989. PMID: 2499626

9

IL-6/IFN-beta-2 as a circulating hormone. Induction by cytokine administration in humans.

Jablons DM, Mulé JJ, McIntosh JK, Sehgal PB, May LT, Huang CM, Rosenberg SA, Lotze MT. Jablons DM, et al. Among authors: lotze mt. J Immunol. 1989 Mar 1;142(5):1542-7. J Immunol. 1989. PMID: 2783945

10

In vivo administration of purified human interleukin 2. II. Half life, immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL 2.

Lotze MT, Matory YL, Ettinghausen SE, Rayner AA, Sharrow SO, Seipp CA, Custer MC, Rosenberg SA. Lotze MT, et al. J Immunol. 1985 Oct;135(4):2865-75. J Immunol. 1985. PMID: 2993418

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

572 results

Search Page

Filters